Thomas McCourt serves as the Chief Executive Officer at Ironwood Pharmaceuticals, Inc., a position he has held since January 2021. With a robust background in the pharmaceutical industry, McCourt brings a wealth of experience to his role. Before joining Ironwood, he was the President and Chief Executive Officer at U.S. Commercial Operations for Teva Pharmaceuticals, where he was responsible for leading the commercial strategy and operations across the United States. His tenure at Teva was marked by significant growth and strategic initiatives that strengthened the company’s market position. McCourt's career in pharmaceuticals spans over two decades, during which he has held various leadership positions that have honed his expertise in commercial strategy, business development, and operational excellence. Prior to Teva, he served as Senior Vice President and Chief Commercial Officer at Endo Pharmaceuticals, where he played a pivotal role in driving the company's commercial success through innovative marketing and sales strategies. His strategic vision and leadership capabilities have been instrumental in navigating complex market dynamics and regulatory environments. As CEO of Ironwood Pharmaceuticals, Thomas McCourt is at the helm of a company focused on developing and commercializing innovative treatments for gastrointestinal diseases. Under his leadership, Ironwood has continued to advance its mission to improve the lives of patients through groundbreaking therapies. McCourt’s strategic direction has been crucial in expanding the company’s pipeline and strengthening its market presence. His commitment to fostering a culture of innovation and excellence is driving Ironwood’s growth and reinforcing its position as a leader in the pharmaceutical industry.